Gsa Capital Partners LLP Jounce Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.64 - $1.99 $33,579 - $104,411	-52,468 Reduced 53.91%	44,849 $50,000
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $265,675 - $478,799	97,317 New	97,317 $228,000
Q4 2021 Feb 14, 2022	SELL	$7.11 - $9.64 $688,959 - $934,116	-96,900 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.04 - $8.73 $223,156 - $386,538	44,277 Added 84.14%	96,900 $720,000
Q2 2021 Aug 05, 2021	BUY	$6.58 - $10.66 $346,259 - $560,961	52,623 New	52,623 $358,000
Q1 2021 May 10, 2021	SELL	$6.73 - $13.87 $206,584 - $425,753	-30,696 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$6.37 - $10.33 $195,533 - $317,089	30,696 New	30,696 $215,000
Q2 2020 Aug 11, 2020	SELL	$4.17 - $7.58 $200,864 - $365,121	-48,169 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$2.91 - $8.7 $140,171 - $419,070	48,169 New	48,169 $229,000
Q4 2019 Feb 12, 2020	SELL	$2.81 - $9.21 $117,772 - $386,009	-41,912 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$3.33 - $4.93 $98,651 - $146,051	29,625 Added 241.11%	41,912 $140,000
Q2 2019 Aug 06, 2019	SELL	$4.3 - $6.73 $113,154 - $177,099	-26,315 Reduced 68.17%	12,287 $61,000
Q1 2019 May 15, 2019	SELL	$3.43 - $6.87 $320,698 - $642,331	-93,498 Reduced 70.78%	38,602 $239,000
Q4 2018 Feb 12, 2019	BUY	$2.69 - $6.71 $75,320 - $187,880	28,000 Added 26.9%	132,100 $445,000
Q3 2018 Nov 13, 2018	BUY	$6.5 - $8.37 $676,650 - $871,316	104,100 New	104,100 $677,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.